- Home
- EML vs SCPH Comparison
EML vs SCPH Comparison
Compare EML & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- SCPH
- Stock Information
- Founded
- EML 1858
- SCPH 2013
- Country
- EML United States
- SCPH United States
- Employees
- EML N/A
- SCPH N/A
- Industry
- EML Industrial Machinery/Components
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- EML Consumer Discretionary
- SCPH Health Care
- Exchange
- EML Nasdaq
- SCPH Nasdaq
- Market Cap
- EML 146.7M
- SCPH 299.0M
- IPO Year
- EML N/A
- SCPH 2017
- Fundamental
- Price
- EML $25.38
- SCPH $5.62
- Analyst Decision
- EML
- SCPH Buy
- Analyst Count
- EML 0
- SCPH 3
- Target Price
- EML N/A
- SCPH $12.00
- AVG Volume (30 Days)
- EML 10.7K
- SCPH 2.4M
- Earning Date
- EML 11-04-2025
- SCPH 11-12-2025
- Dividend Yield
- EML 1.73%
- SCPH N/A
- EPS Growth
- EML N/A
- SCPH N/A
- EPS
- EML N/A
- SCPH N/A
- Revenue
- EML $269,054,445.00
- SCPH $49,969,000.00
- Revenue This Year
- EML $1.56
- SCPH $108.95
- Revenue Next Year
- EML $7.00
- SCPH $78.30
- P/E Ratio
- EML $13.98
- SCPH N/A
- Revenue Growth
- EML 1.30
- SCPH 107.79
- 52 Week Low
- EML $19.06
- SCPH $1.94
- 52 Week High
- EML $35.03
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- EML 60.90
- SCPH 52.96
- Support Level
- EML $23.50
- SCPH N/A
- Resistance Level
- EML $25.46
- SCPH $5.62
- Average True Range (ATR)
- EML 0.69
- SCPH 0.04
- MACD
- EML 0.16
- SCPH -0.21
- Stochastic Oscillator
- EML 93.03
- SCPH 99.56
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.